CMS, CDC, and HHS Seek Public Input on Potential CLIA Updates
Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), and the Department of Health and Human Services...
1 min read
The legislative spending package passed in Congress on Nov. 12 includes a provision that delays steep cuts to the Medicare Clinical Laboratory Fee Schedule (CLFS) for 30 days.
The bill (H.R. 5371) ends the government shutdown by providing fiscal year 2026 continuing appropriations for most federal agencies through Jan. 30, 2026. The CLFS cuts, expected to result in up to a 15 percent decrease for more than 800 tests, would have taken effect on Jan. 1, 2026, if this bill had not passed.
Section 6209 of the legislation revised the phase-in of reductions from private payer rate implementation and the reporting period for private sector payment rates for the establishment of Medicare payment rates.
The College of American Pathologists is among the stakeholder organizations calling for foundational reform to permanently repair the CLFS through the RESULTS Act (H.R. 5269/S.2761). This bill seeks to “provide long-term stability” for the CLFS “by improving the accuracy of, and feasibility of data collection for … payment rates applied under the Medicare program” for laboratory tests.
Sources:
https://www.congress.gov/bill/119th-congress/house-bill/5371/text
https://www.cap.org/advocacy/latest-news-and-practice-data/november-11-2025#story1
White Paper: The in-house vs. outsourced billing questions answered
Most labs answer them as one, and that is what makes the decision expensive. Separating them is what makes it reversible. BY TELCOR WITH KWAMI...
CMS Releases October Quarterly Update to CLFS and CLIA HCPCS Codes
The Centers for Medicare & Medicaid Services (CMS) posted the October 2026 Quarterly Update to the Clinical Laboratory Fee Schedule (CLFS) and...